Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2022, Vol. 36 ›› Issue (3): 171-180.doi: 10.6040/j.issn.1673-3770.0.2021.556
Previous Articles Next Articles
LI Lin1, GAO Zhengwen2, CUI Nan3, SUN Jianping4, HUANG Xianming5, CUI Jing4
CLC Number:
[1] Heath J, Hartzell L, Putt C, et al. Chronic rhinosinusitis in children: pathophysiology, evaluation, and medical management[J]. Curr Allergy Asthma Rep, 2018, 18(7): 37. doi:10.1007/s11882-018-0792-8. [2] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi:10.3760/cma.j.issn.1673-0860.2019.02.001. [3] Cho SH, Hamilos DL, Han DH, et al. Phenotypes of chronic rhinosinusitis[J]. J Allergy Clin Immunol Pract, 2020, 8(5): 1505-1511. doi:10.1016/j.jaip.2019.12.021. [4] 李华斌, 曹玉洁. 儿童鼻窦炎的临床诊疗进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(6): 16-19. doi:10.6040/j.issn.1673-3770.1.2019.057. LI Huabin, CAO Yujie. Diagnosis and treatment of pediatric rhinosinusitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 16-19.doi:10.6040/j.issn.1673-3770.1.2019.057. [5] Mahdavinia M, Grammer LC 3rd. Chronic rhinosinusitis and age: is the pathogenesis different? [J]. Expert Rev Anti Infect Ther, 2013, 11(10): 1029-1040. doi:10.1586/14787210.2013.839380. [6] Snidvongs K, Sangubol M, Poachanukoon O. Pediatric versus adult chronic rhinosinusitis[J]. Curr Allergy Asthma Rep, 2020, 20(8): 29. doi:10.1007/s11882-020-00924-6. [7] Ghogomu N, Kern R. Chronic rhinosinusitis: the rationale for current treatments[J]. Expert Rev Clin Immunol, 2017, 13(3): 259-270. doi:10.1080/1744666X.2016.1220833. [8] 刘佳, 付勇. 儿童慢性鼻窦炎的外科治疗研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(6): 29-33. doi:10.6040/j.issn.1673-3770.1.2019.060. LIU Jia, FU Yong. Advances in the surgical treatment of pediatric patients with chronic rhinosinusitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(6): 29-33.doi:10.6040/j.issn.1673-3770.1.2019.060. [9] Gilani S, Shin JJ. The burden and visit prevalence of pediatric chronic rhinosinusitis[J]. Otolaryngol Head Neck Surg, 2017, 157(6): 1048-1052. doi:10.1177/0194599817721177. [10] Bhattacharyya N, Villeneuve S, Joish VN, et al. Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps[J]. Laryngoscope, 2019, 129(9): 1969-1975. doi:10.1002/lary.27852. [11] 陈钢, 于洋, 王林娥. 慢性鼻-鼻窦炎伴鼻息肉基因表达谱的生物信息学分析[J]. 激光生物学报, 2020, 29(2): 161-167. doi:10.3969/j.issn.1007-7146.2020.02.010. CHEN Gang, YU Yang, WANG Line. Bioinformatics analysis of the gene expression profile in chronic rhinosinusitis with nasal polyps[J]. Acta Laser Biology Sinica, 2020, 29(2): 161-167. doi:10.3969/j.issn.1007-7146.2020.02.010. [12] Ryu G, Kim DK, Dhong HJ, et al. Immunological characteristics in refractory chronic rhinosinusitis with nasal polyps undergoing revision surgeries[J]. Allergy Asthma Immunol Res, 2019, 11(5): 664-676. doi:10.4168/aair.2019.11.5.664. [13] Chen FH, Hong HY, Sun YQ, et al. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: a pilot study[J]. Ann Allergy Asthma Immunol, 2017, 119(4): 310-316.e2. doi:10.1016/j.anai.2017.07.012. [14] Tsybikov NN, Egorova EV, Kuznik BI, et al. Neuron-specific enolase in nasal secretions as a novel biomarker of olfactory dysfunction in chronic rhinosinusitis[J]. Am J Rhinol Allergy, 2016, 30(1): 65-69. doi:10.2500/ajra.2016.30.4264. [15] Drake VE, Rafaels N, Kim J. Peripheral blood eosinophilia correlates with hyperplastic nasal polyp growth[J]. Int Forum Allergy Rhinol, 2016, 6(9): 926-934. doi:10.1002/alr.21793. [16] Yu JQ, Kang X, Xiong YP, et al. Gene expression profiles of circular RNAs and microRNAs in chronic rhinosinusitis with nasal polyps[J]. Front Mol Biosci, 2021, 8: 643504. doi:10.3389/fmolb.2021.643504. [17] Kartush AG, Schumacher JK, Shah R, et al. Biologic agents for the treatment of chronic rhinosinusitis with nasal polyps[J]. Am J Rhinol Allergy, 2019, 33(2): 203-211. doi:10.1177/1945892418814768. [18] Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps(liberty np sinus-24 and liberty np sinus-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials[J]. Lancet, 2019, 394(10209): 1638-1650. doi:10.1016/S0140-6736(19)31881-1. [19] Gevaert P, Omachi TA, Corren J, et al. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials[J]. J Allergy Clin Immunol, 2020, 146(3): 595-605. doi:10.1016/j.jaci.2020.05.032. [20] Paramasivan S, Bassiouni A, Shiffer A, et al. The international sinonasal microbiome study: a multicentre, multinational characterization of sinonasal bacterial ecology[J]. Allergy, 2020, 75(8): 2037-2049. doi:10.1111/all.14276. [21] Man WH, de Steenhuijsen Piters WAA, Bogaert D. The microbiota of the respiratory tract: gatekeeper to respiratory health[J]. Nat Rev Microbiol, 2017, 15(5): 259-270. doi:10.1038/nrmicro.2017.14. [22] Drago L, Pignataro L, Torretta S. Microbiological aspects of acute and chronic pediatric rhinosinusitis[J]. J Clin Med, 2019, 8(2): E149. doi:10.3390/jcm8020149. [23] Welp AL, Bomberger JM. Bacterial community interactions during chronic respiratory disease[J]. Front Cell Infect Microbiol, 2020, 10: 213. doi:10.3389/fcimb.2020.00213. [24] Gu X, Yao XC, Liu DT. Up-regulation of microRNA-335-5p reduces inflammation via negative regulation of the TPX2-mediated AKT/GSK3β signaling pathway in a chronic rhinosinusitis mouse model[J]. Cell Signal, 2020, 70: 109596. doi:10.1016/j.cellsig.2020.109596. [25] Vergadi E, Ieronymaki E, Lyroni K, et al. Akt signaling pathway in macrophage activation and M1/M2 polarization[J]. J Immunol, 2017, 198(3): 1006-1014. doi:10.4049/jimmunol.1601515. |
[1] | AO Tian,CHENG Lei. An endotype study of chronic rhinosinusitis with nasal polyps and precise control and treatment under the guidance [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 7-14. |
[2] | YAO Shuang,LOU Hongfei. Advances in endotypes and precision medicine in chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 20-29. |
[3] | SHI Shuai, ZHENG Quan,CHENG Lei. Research advances of dupilumab in the treatment of chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 36-42. |
[4] | WANG Huan, HU Li,YU Hongmeng. Research progress of olfactory dysfunction in chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 43-49. |
[5] | YI Ruonan,CHEN Fuquan. Eosinophils and Olfactory Dysfunction [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 50-55. |
[6] | GU Yu, WAN Xin,XIAO Zi'an. The interaction between neutrophils and eosinophils in chronic rhinosinusitis and the implications on treatment options [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 56-63. |
[7] | LIN Hai, ZHU Ying,ZHANG Weitian. The roles of ion channels in the pathogenesis of chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 64-70. |
[8] | QIAO Xinjie,. Research progress on the signal transduction pathway and other factors related to epithelial-mesenchymal transformation in chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 71-77. |
[9] | HUANG Danyi, ZHANG Ting,CHEN Jing, ZHANG Wei. Progress of research regarding the role of the epithelial barrier in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 78-83. |
[10] | LI Jiani, ZHU Dongdong,MENG Cuida. The role of epigenetics in the pathogenesis of chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 84-91. |
[11] | CAO Xuan,XIAO Xuping, LI Yunqiu. Advances in the application of hyaluronic acid in chronic sinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 104-109. |
[12] | WANG Na,CHAI Xiangbin. Research progress on prostate-derived ETS factor in asthma and inflammatory diseases of the nasal mucosa [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 136-141. |
[13] | LIU Yitong, ZHOU Suizi,QIU Qianhui. Research progress on NLRP3 inflammasome in chronic rhinosinusitis and allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 142-146. |
[14] | CHEN Shiqin, WEI Pingcun, HU Yunlong, HU Jinwang. Effects of three different nasal uses of glucocorticoid on mucosal outcome after endoscopic sinus surgery [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 195-201. |
[15] | LIN Manqing, ZHOU Min, CHEN Tengyu, LI-Dan, FANG Caishan, WANG Ruizhi, ZHU Jinxiang, RUAN-Yan, XU Huixian, WANG Peiyuan. Meta-analysis of the efficacy and safety of traditional Chinese medicine for nasal irrigation in the treatment of chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 209-225. |
|